28
Oct
2025
Seacross Pharmaceuticals
Exhibitor at CPHI Frankfurt 2025 stand 3.1B48, Finished Dosage Formulations
About Us
Categories
-
CN
-
2015On CPHI since
-
2Certificates
-
1000 - 4999Employees
Company types
Primary activities
Event information
CPHI Frankfurt 2025
-
28 Oct 2025 - 30 Oct 2025
-
Messe, Frankfurt
-
Visit us at stand 3.1B48, Finished Dosage Formulations
Products Featured at CPHI Frankfurt 2025
-
Product Azacitidine Seacross 25mg/ml Powder for suspension for injection
Therapeutic indications:Azacitidine Seacross is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (HSCT) with:
•intermediate-2 and high-risk myelodysplastic syndromes (MDS) according to the International Prognostic Scoring System ... -
Product Zoledronic Acid Seacross 5mg/100ml solution for infusion
Therapeutic indications:
Treatment of osteoporosis:•in post-menopausal women•in adult men at increased risk of fracture, including those with a recent low-trauma hip fracture.Treatment of osteoporosis associated with long-term systemic glucocorticoid therapy: •in post-menopausal wo... -
Product Docetaxel 20 mg/ml Concentrate for solution for infusion
Therapeutic indications:Breast cancer, sarcoma, small-cell carcinoma of the lung, Hodgkin disease or non-Hodgkin lymphoma, acute leukaemia, cancer of the thyroid, bladder, ovaries, Paediatric tumours, such as neuroblastoma. Doxorubicin is frequently used in combination chemotherapy regimens with other... -
Product API: Carfilzomib/Bortezomib/Thiotepa/Ferric Carboxymaltose/Goserelin acetate/Ixazomib citrate
——1. Carfilzomib: commercial API, DMF available, W.C. to be available in April 2024 2024)——Bortezomib: commercial API, DMF available, W.C. to be available in April 2024
——2. Thiotepa:
Commercial API, DMF available, W.C. to be available in April 2024
——3. Ferric carboxymaltose: ... -
Product Paclitaxel 6 mg/ml concentrate for solution for infusion
Paclitaxel Injection is used to treat:
Ovarian cancer:
• as first therapy (after initial surgery in combination with the platinum-containing medicine cisplatin).
• after standard platinum-containing medicines have been tried but did not work.
...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance